Yuvia Alhelí Pérez Rico

Yuvia Alhelí Pérez Rico has worked in the field of genomics since 2011. From 2011-2014, they were a Guest Scientist at the Max-Planck Institute for Molecular Biomedicine, where they identified transcriptional changes during wound healing and early regeneration in planarians. From 2014-2019, they were a Research Assistant at Institut Curie, where they annotated and characterized gene regulatory regions, and a PhD student at Sorbonne Universit\u00e9, where they conducted a comparative analysis of regulatory elements in vertebrate genomes and studied the role of CTCF during zebrafish development. From 2019-2022, they were a Postdoctoral Fellow and a Marie Curie Individual Fellow at EMBL, where they identified transcription factors involved in the regulation of genes that are expressed from the inactive X chromosome in mouse. Yuvia Alhelí is currently employed as a Computational Biologist at Cimeio Therapeutics.

Yuvia Alhelí Pérez Rico obtained their Bachelor's degree in Genome Sciences/Genomics from the Universidad Nacional Autónoma de México between 2008 and 2012. Yuvia Alhelí then went on to earn their Master's degree in Life Sciences from the Ecole normale supérieure in 2013-2014. Lastly, they completed their Doctor of Philosophy - PhD in Genome Sciences/Genomics from Sorbonne Université in 2018.